The effect of antagonists of various subtypes of dopamine receptors on the locomotor activity of C57BL mice in the presence of psychostimulants

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 66, Issue 6, 2003, Pages 3-5

  Novoselov, I A ^a   Raevsky, K S ^a  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CLOZAPINE; DEXAMPHETAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; PSYCHOSTIMULANT AGENT; RACLOPRIDE; RECEPTOR SUBTYPE; SYDNOCARB; CENTRAL STIMULANT AGENT; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; SYDNONE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DRUG MECHANISM; HYPERACTIVITY; LOCOMOTION; MOUSE; NONHUMAN; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; MOTOR ACTIVITY;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SYDNONES;

EID: 1842781030     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. I. I. Afanas'ev, E. A. Anderzhanova, V. S. Kudrin, and K. S. Rayevsky, Pharmacol. Biochem. Behav., 69, 653-658 (2001).
2. S. Cabib, C. Castellano, V. Cestari, et al., Psychopharmacol., 105, 335-339 (1991).
3. A. K. Cho, and S. D. Segal, Amphetamine and its analogs, Academic Press, San Diego (1994).
4. R. R. Gainetdinov, T. D. Sotnikova, T. V. Grekhova, and K. S. Rayevsky, Eur. J. Pharmacol., 340, 53-58 (1997).
5. A. Lang, E. Vasar, A. Soosaar, and J. Harro, Pharmacol. Toxicol., 71(2), 132-138 (1992).
6. M. J. Millan, A. Gobert, A Newman-Tancredi, et al., J. Pharm. Exp. Therap., 286(3), 1356-1373 (1998).
7. M. F. O'Neill, and G. Shaw, Psychopharmacol., 145(3), 237-250 (1999).
8. S. O. Ogren, L. Rosen, and K. Fuxe, Neuroscience, 61(2), 269-283 (1994).
9. N. Petry, L. Furmidge, Z-Y. Tong, et al., Pharmacol. Biochem. Behavior., 44, 167-180 (1993).
10. G. Skuza, Z. Rogoz, and A. Wieczorek, Pol. J. Pharmacol., 49(1), 5-15 (1997).
11. J. M. Witkin, N. Savtchenko, M. Mashkovsky, et al., J. Pharm. Exp. Therap., 288, 1298-1310 (1999).